These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173 [No Abstract] [Full Text] [Related]
4. Biologicals for cancer treatment: monoclonal antibodies. Levy R Hosp Pract (Off Ed); 1985 Nov; 20(11):67-74, 77, 80-4 passim. PubMed ID: 3932392 [No Abstract] [Full Text] [Related]
5. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab. Nagorsen D; Bargou R; Ruttinger D; Kufer P; Baeuerle PA; Zugmaier G Leuk Lymphoma; 2009 Jun; 50(6):886-91. PubMed ID: 19455460 [TBL] [Abstract][Full Text] [Related]
7. [Serotherapy of leukemia and lymphoma using monoclonal antibodies]. Rupniewska ZM Pol Tyg Lek; 1985 Aug; 40(33):942-7. PubMed ID: 2997760 [No Abstract] [Full Text] [Related]
8. [Monoclonal antibodies for lymphomas and leukemias in 2005]. Peffault de Latour R; Robin M; Bay JO Bull Cancer; 2006 Jan; 93(1):107-18. PubMed ID: 16455513 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody therapy of lymphomas and leukemia. Kaminski MS; Foon KA Cancer Treat Res; 1988; 38():253-63. PubMed ID: 2908598 [No Abstract] [Full Text] [Related]
11. CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy. Scheuermann RH; Racila E Leuk Lymphoma; 1995 Aug; 18(5-6):385-97. PubMed ID: 8528044 [TBL] [Abstract][Full Text] [Related]
12. Use of anti-idiotypic antibodies to treat lymphoid tumors. Stevenson GT Methods Enzymol; 1989; 178():341-55. PubMed ID: 2481211 [No Abstract] [Full Text] [Related]
13. New approaches to the treatment of non-Hodgkin's lymphoma. Frei E; Schlossman S; Israel M Cancer Treat Rep; 1977 Sep; 61(6):1209-17. PubMed ID: 332355 [No Abstract] [Full Text] [Related]
14. Anti-idiotype antibodies reveal the existence of somatic mutation in human B cell lymphoma. Levy R; Levy S; Brown SL; Kon S; Carroll W Monogr Allergy; 1987; 22():194-203. PubMed ID: 3325832 [No Abstract] [Full Text] [Related]
15. Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy. Verhoeven D; Stoppelenburg AJ; Meyer-Wentrup F; Boes M Clin Immunol; 2018 May; 190():22-31. PubMed ID: 29499421 [TBL] [Abstract][Full Text] [Related]
16. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5]. Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297 [TBL] [Abstract][Full Text] [Related]
17. Targeting malignant B cells of lymphoma and leukemia with genetically engineered T-cell clones. Jensen MC Cytotherapy; 2002; 4(5):443-4. PubMed ID: 12473219 [No Abstract] [Full Text] [Related]
18. Clinical applications of monoclonal antibodies for patients with leukemia and lymphoma. Foon KA; Schroff RW; Bunn PA Prog Clin Biol Res; 1986; 211():265-84. PubMed ID: 3515361 [No Abstract] [Full Text] [Related]
19. Prospects for monoclonal antibody therapy of leukemia and lymphoma. Badger CC; Bernstein ID Cancer; 1986 Jul; 58(2 Suppl):584-9. PubMed ID: 3521840 [TBL] [Abstract][Full Text] [Related]